SARTORIUS AG - ADR (SSSGY:OTCMKTS)
$0 None (None%)
Analysed SARTORIUS AG - ADR (SSSGY:OTCMKTS) News Sources
Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA
01-12-2025
yahoo.com
Sartorius Aktiengesellschaft Q4 Earnings Call Highlights
03-02-2026
marketbeat.com
[Latest] Global Large And Small Scale Bioprocessing Market Size/Share Worth USD 277.4 Billion by 2035 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Growth Rate, Value, SWOT Analysis)
10-02-2026
yahoo.com
Sartorius Releases Annual Report for 2025
16-02-2026
yahoo.com
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More
19-02-2026
yahoo.com
Assessing Sartorius (XTRA:SRT3) Valuation After Share Price Weakness And A High P/E Multiple
15-05-2026
yahoo.com
Sartorius Opens New Competence Center for cell and Gene Therapy Components in Freiburg, Germany
21-05-2026
yahoo.com
What is the current price of SARTORIUS AG - ADR (SSSGY:OTCMKTS)?
The current price of SARTORIUS AG - ADR (SSSGY:OTCMKTS) is $0.
SARTORIUS AG - ADR (SSSGY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SARTORIUS AG - ADR (SSSGY:OTCMKTS) since the previous trading day is $None.
SARTORIUS AG - ADR (SSSGY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SARTORIUS AG - ADR (SSSGY:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for SARTORIUS AG - ADR (SSSGY:OTCMKTS)?
The most recent average sentiment score for SARTORIUS AG - ADR (SSSGY:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for SARTORIUS AG - ADR (SSSGY:OTCMKTS)?
The most recent sentiment for SARTORIUS AG - ADR (SSSGY:OTCMKTS) is .
SEC-8K** Filing Available For SARTORIUS AG - ADR (SSSGY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.